Investor Rights Firm Investigates Four Companies' Transactions

Law firm Halper Sadeh LLC has initiated investigations into four publicly traded companies concerning their ongoing or proposed corporate transactions. The companies under scrutiny are Lifecore Biomedical, Inc., Integer Holdings Corporation, First Hawaiian, Inc., and Indivior Pharmaceuticals, Inc.

The investigations aim to determine whether the companies' management and boards have acted in the best interests of shareholders and complied with federal securities laws in the terms of these transactions. Halper Sadeh LLC stated it is specifically examining "whether the companies are obtaining fair deals for their shareholders."

Transactions under review include the sale of Lifecore Biomedical to Webster Equity Partners for $6.28 per share in cash plus a non-tradable contingent value right per share. Integer Holdings Corporation's sale to KKR for $127.00 per share is also being investigated. Mergers involving First Hawaiian with TriCo Bancshares and Indivior Pharmaceuticals with Supernus Pharmaceuticals, Inc., where shareholder ownership in the combined entities is significant, are also part of the inquiry.

Halper Sadeh LLC is encouraging any shareholders of the affected companies to contact the firm to discuss their rights and options. The firm indicated that they handle such matters on a contingency fee basis, meaning clients would not be responsible for out-of-pocket legal fees or expenses. The firm seeks to obtain increased consideration, additional disclosures, or other benefits for shareholders in these transactions, noting that insiders may receive substantial financial benefits not available to ordinary shareholders.